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Dr Michael Stoner (Greenville, NC). I enjoyed the presen-
tation and would first like to thank the authors for the ability to
review the study prior to the meeting. This continues the trend of
the Nationwide Inpatient Sample (NIS) data that we’ve seen at the
meeting in the last couple days, with a similar spin coming out over
and over again. These presentations are consistently showing a
higher stroke rate for carotid artery stenting (CAS). The purpose of
this paper is to show the influence of age on carotid revasculariza-
tion outcomes, both carotid endarterectomy (CEA) and CAS. I
have a few questions for the authors regarding the study.
First of all, I realize that the NIS does not have temporal data
with respect to the codes used to select for stroke, so the authors
selected procedures within 48 hours of admission. Therefore, they
attempted to not select out those patients who are in-house and
already have a stroke. I’d like the authors to expand on this. Were
most of these procedures done within 24 hours? In other words,
can you tighten up the data a little bit to 24 hours or less, and be
sure that you’re really looking at elective data.
Secondly, your note that the mortality rate was higher in
octogenarians. I was wondering if the NIS data will help us answer
exactly why that is. Do you note more hemorrhagic strokes in the
patients greater than 80 years of age who have a neurological
complication from CAS or CEA?
And lastly, how do these data impact your practice? If we used
a traditional surgical metric of stroke-death, carotid artery stenting
is the loser at all points in your study. What do the authors advocate
with respect to the use of CAS in the elderly?
Dr Vogel. Thank you for your questions. First, we decided to
limit the study cohort to focus on elective CAS procedures. We chose
to evaluate surgeries performed within 48-hours of admission to
attempt to include only elective procedures. However, the majority of
the procedures were performed within the first 24-hour period.
Regarding the second question, the reality is the stroke codes
contained in administrative data are a significant source of confu-
sion based on the limitations of the data. The code most commonly
evaluated in administrative studies is the code for “iatrogenic
stroke”. This is likely under-coded, based on the ability of the
coders at each institution to identify iatrogenic vs all other strokes,
and is an inherent limitation of the dataset. Administrative data isunder-coded by hospitals and we have started a validation study to
further analyze this. For this reason, we have included other codes
for stroke. Stroke is considered an acute diagnosis and by limiting
the cohort as we have to elective procedures we feel our data
represents a more accurate description of stroke after CAS inter-
ventions than other studies using the same NIS dataset. I believe
our study demonstrates that octogenarians do not have a higher
stroke rate after CAS than other patients, but that CAS has a higher
stroke rate than CEA overall. Stroke was the strongest predictor of
mortality, CAS was more often utilized in the elderly, and CAS
carries a higher stroke rate than CEA. This, we believe, accounts
for the higher mortality seen in the elderly.
Finally, regarding your question describing how this data will
impact my practice. We have found CAS to be inferior to CEA
using the NIS data. I believe the use of CAS should be based on the
individual patient with the knowledge that it has a higher stroke
rate than CEA in retrospective administrative data. The choice of
CEA vs CAS must be tempered with patient comorbidities to make
an appropriate decision for each individual patient and this is how
we have modified our practice. Prospective studies, such as the
CREST trial, are needed to answer this question appropriately.
Dr Martin Back (Tampa, Fla). Hospital’s code diagnoses for
patients to maximize reimbursement so the more comorbidities
they document from a chart, the greater the potential revenue.
How accurate do you think these diagnoses are for a given patient?
Your analysis for prognostic variables related to intervention tech-
nique is dependent on that accuracy to give meaningful results.
DrVogel. Yes, the NIS is administrative data based on billing. It
is retrospective data. The code for stroke should not be contained in
the data unless the patient had a stroke at that hospitalization, as it is
considered an acute diagnosis and we limited the cohort to elective
CAS procedures. The reason that the fluid and electrolyte were noted
is that it is one of the 29 Elixhauser comorbidity used in evaluating
administrative data. The Elixhauser comorbidities are a validated tool
for adjusting for comorbidities in administrative data.
Prospective trials are needed to obtain the final answer regard-
ing CAS, and results from these studies using administrative data
are retrospective and should be considered hypothesis generating
as well as reflective of large populations.
